Taro Pharmaceutical Indus TARO reported its Q3 earnings results on Thursday, January 27, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Taro Pharmaceutical Indus missed estimated earnings by 23.08%, reporting an EPS of $0.7 versus an estimate of $0.91, which surprised analysts.
Revenue was up $1.15 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.36, which was followed by a 7.14% drop in the share price the next day.
Here's a look at Taro Pharmaceutical Indus's past performance:
| Quarter | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|
| EPS Estimate | 1.02 | 0.84 | 0.92 | 1.01 |
| EPS Actual | 0.66 | 1.09 | 0.81 | 0.86 |
| Revenue Estimate | 153.23M | 137.23M | 147.33M | 152.63M |
| Revenue Actual | 131.99M | 147.11M | 148.35M | 140.15M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
